Page last updated: 2024-09-04

ivabradine and Angor Pectoris

ivabradine has been researched along with Angor Pectoris in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	44 (48.89)	29.6817
2010's	45 (50.00)	24.3611
2020's	1 (1.11)	2.80

Authors

Authors	Studies
Chen, T; Fang, X; Huang, J; Xu, X; Zhao, Q; Zheng, J; Zhu, H	1
Gluud, C; Jakobsen, JC; Maagaard, M; Nielsen, EE; Ning, L; Sethi, NJ; Yang, SH	1
Bouvaist, H; Cosgrove, S; Ennezat, PV; Le Jemtel, TH; Marechaux, S; Vital Durand, D	1
Crea, F; Di Franco, A; Di Monaco, A; Lamendola, P; Lanza, GA; Nerla, R; Sarullo, FM; Sestito, A; Tarzia, P; Villano, A	1
Jacobshagen, C	1
Jones, DA; Timmis, A; Wragg, A	1
Bourke, JP; Keavney, BD; Koref, MS; Martin, RI; Pogoryelova, O; Teare, MD	1
Cowie, MR	1
Lohmann, M	1
Chassany, O; Ferrari, R; Ford, I; Fox, K; Steg, PG; Tardif, JC; Tendera, M	1
Hu, D; Sun, Y; Yu, J	1
Nguyen, E; Weeda, ER; White, CM	1
Colombo, A; Fragasso, G; Fumero, A; Giannini, F; Godino, C; Maranta, F; Margonato, A; Oppizzi, M; Slavich, M	1
Fortmüller, U	1
de Silva, R; Giavarini, A	1
Alshammari, TM	1
Astashkin On Behalf Of The Linkor Study Investigators, EI; Glezer, MG	1
Tardif, JC	2
Deev, AD; Karpov, IuA	1
Biriuchenko, MV; Pozdniakova, NV; Tatarchenko, IP	1
Arora, R; Jawad, E	1
van de Borne, P	1
Stieber, J	1
Kahan, T; Ponikowski, P; Tardif, JC	1
D'Orazio, N; Riccioni, G; Vitulano, N	1
Sajadieh, A	1
Riccioni, G	2
Fomin, IV; Valikulova, FIu	1
Gray, D; Prasad, UK; Purcell, H	1
de Silva, R; Fox, KM	1
Borer, JS; Tardif, JC; Tendera, M	1
Ferrari, R; Ford, I; Fox, K; Robertson, M; Steg, PG; Tendera, M	1
Kaehler, J; Köster, R; Meinertz, T	1
Borer, JS; Tardif, JC	1
Lopatin, IuM	2
D'Angelo, L; Fazio, G; Licata, P; Novo, G; Novo, S; Passantino, S; Sarulo, F; Spanò, C; Visconti, C; Zarcone, P	1
Ebelt, H; Kaehler, J; Koester, R; Meinertz, T; Soeffker, G; Werdan, K	1
Battler, A; Dvir, D	1
Kaehler, J; Koester, R; Meinertz, T	1
Lebedev, EV; Shkol'nik, EL; Vasiuk, IuA	1
Bhargava, B; Parakh, N	1
Kosheleva, NA; Rebrov, AP	1
Ageev, FT; Makarova, GV; Orlova, IaA; Patrusheva, IF	1
Massé, JF	1
Feola, M; Lombardo, E; Menditto, E; Nervo, E; Piccolo, S; Taglieri, C	1
Glezer, MG; Saĭgitov, RT	1
Köster, R; Meinertz, T	1
Mach, F	1
Carbajal, EV; Deedwania, PC	1
Bonadei, I; Bontempi, L; Curnis, A; D'Aloia, A; Dei Cas, L; Del Magro, F; Piovanelli, B; Vizzardi, E	1
Athanasiadis, A; Sechtem, U	1
Anzai, T	1
Boissel, JP; Chabaud, S; Girard, P; Nony, P	1
Borer, JS; Fox, K; Jaillon, P; Lerebours, G	1
Er, F; Hoppe, UC	1
Bourassa, MG; Ford, I; Fox, K; Tardif, JC; Tendera, M	1
Marber, MS; Saha, M	1
Borer, JS	3
Barsness, GW; Yang, EH	1
Sulfi, S; Timmis, AD	1
Fox, K	1
Hennersdorf, MG	1
Diaz, A; Tardif, JC	1
Camm, AJ; Savelieva, I	1
Belousov, IuB; Erofeeva, SB; Maneshina, OA	1
Hoppe, UC	1
Haghfelt, TH	1
Barbuti, A; Baruscotti, M; Bucchi, A; DiFrancesco, D	1
Ford, I; Fox, KM; Ruzyllo, W; Tendera, M	1
César, LA	1
Menown, IB	1
Filipova, S; López-Bescós, L; Martos, R	1
Andrikopoulos, G; Dasopoulou, C; Kappos, K; Koulouris, S; Kranidis, A; Manolis, AS; Sakellariou, D; Tzeis, S	1
Chaitman, BR; Sano, J	1
Izzat, LM	1

Reviews

42 review(s) available for ivabradine and Angor Pectoris

Article	Year
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials. Clinical therapeutics, 2019, Volume: 41, Issue:10 Topics: Angina Pectoris; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome	2019
Effects of adding ivabradine to usual care in patients with angina pectoris: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. Open heart, 2020, Volume: 7, Issue:2 Topics: Aged; Angina Pectoris; Cardiovascular Agents; Female; Humans; Ivabradine; Male; Middle Aged; Patient Safety; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome	2020
Limited role and benefit of ivabradine in the treatment of angina and heart failure with reduced ejection fraction. Acta cardiologica, 2017, Volume: 72, Issue:6 Topics: Angina Pectoris; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome	2017
[Late sodium current and calcium overload--pathogenesis and adequate treatment]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:16 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Benzazepines; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Electrocardiography; Endothelium, Vascular; Heart Failure, Diastolic; Humans; Hypercalcemia; Ivabradine; Myocardial Ischemia; Nitrates; Piperazines; Ranolazine; Sodium; Sodium Channels; Sodium-Calcium Exchanger	2013
Novel drugs for treating angina. BMJ (Clinical research ed.), 2013, Sep-09, Volume: 347 Topics: Acetanilides; Angina Pectoris; Benzazepines; Enzyme Inhibitors; Heart Rate; Humans; Ivabradine; Nicorandil; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents	2013
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials. Heart (British Cardiac Society), 2014, Volume: 100, Issue:19 Topics: Angina Pectoris; Atrial Fibrillation; Benzazepines; Heart Failure; Humans; Incidence; Ivabradine; Randomized Controlled Trials as Topic; Risk Assessment	2014
Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:6 Topics: Angina Pectoris; Benzazepines; Canada; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Myocardial Infarction; Stroke Volume; Treatment Outcome	2016
The Role of Ivabradine in the Management of Angina Pectoris. Cardiovascular drugs and therapy, 2016, Volume: 30, Issue:4 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Heart Rate; Humans; Ivabradine	2016
Ivabradine: Do the Benefits Outweigh the Risks? Journal of cardiovascular pharmacology and therapeutics, 2017, Volume: 22, Issue:3 Topics: Angina Pectoris; Benzazepines; Bradycardia; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Patient Safety; Recovery of Function; Risk Assessment; Risk Factors; Treatment Outcome; Ventricular Function, Left	2017
Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases. Drugs of today (Barcelona, Spain : 1998), 2008, Volume: 44, Issue:3 Topics: Angina Pectoris; Animals; Benzazepines; Cardiotonic Agents; Cardiovascular Diseases; Heart Rate; Humans; Ivabradine	2008
Chronic stable angina pectoris. Disease-a-month : DM, 2008, Volume: 54, Issue:9 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetanilides; Angina Pectoris; Antihypertensive Agents; Benzazepines; Bosentan; Chronic Disease; Counterpulsation; Cyclic Nucleotide-Gated Cation Channels; Exercise Test; Heart Murmurs; Humans; Ivabradine; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Nicorandil; Oxygen Consumption; Perhexiline; Piperazines; Protein Kinase Inhibitors; Ranolazine; Sulfonamides; Trimetazidine; Vasodilator Agents	2008
[What are the alternatives to betablockers in 2009?]. Revue medicale de Bruxelles, 2008, Volume: 29, Issue:4 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiomyopathies; Heart Failure; Heart Valve Diseases; Humans; Ivabradine; Myocardial Infarction; Myocardial Ischemia; Patient Selection; Stereoisomerism; Vasodilator Agents	2008
Ivabradine for stable angina? Drug and therapeutics bulletin, 2008, Volume: 46, Issue:11 Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Humans; Ivabradine; Treatment Outcome	2008
Ivabradine: pharmacodynamic aspects of its clinical use. Methods and findings in experimental and clinical pharmacology, 2008, Volume: 30, Issue:8 Topics: Angina Pectoris; Animals; Benzazepines; Chronic Disease; Cyclic Nucleotide-Gated Cation Channels; Heart Rate; Humans; Ion Channels; Ivabradine	2008
Ivabradine: beyond heart rate control. Advances in therapy, 2009, Volume: 26, Issue:1 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Nitrates; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left	2009
Focus on ivabradine: a new heart rate-controlling drug. Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:2 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Heart Rate; Humans; Ivabradine; Risk Factors; Vision Disorders	2009
Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina. Advances in therapy, 2009, Volume: 26, Issue:2 Topics: Action Potentials; Angina Pectoris; Benzazepines; Chronic Disease; Cyclic Nucleotide-Gated Cation Channels; Exercise Test; Heart Rate; Humans; Ivabradine; Membrane Transport Modulators; Patient Selection; Quality of Life; Safety; Sinoatrial Node; Treatment Outcome	2009
Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris. Cardiology, 2009, Volume: 114, Issue:2 Topics: Age Distribution; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Coronary Artery Bypass; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Humans; Incidence; Ivabradine; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Severity of Illness Index; Sex Distribution; Survival Rate; Treatment Outcome	2009
[Ivabradine in the treatment of patients with angina pectoris: lessons of the BEAUTIFUL trial]. Kardiologiia, 2010, Volume: 50, Issue:1 Topics: Angina Pectoris; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Humans; Ivabradine; Randomized Controlled Trials as Topic; Treatment Outcome	2010
Conventional and novel drug therapeutics to relief myocardial ischemia. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine	2010
Rate control with ivabradine: angina pectoris and beyond. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2011, Volume: 11, Issue:1 Topics: Acute Coronary Syndrome; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Heart Failure; Heart Rate; Humans; Ivabradine	2011
Ivabradine: recent and potential applications in clinical practice. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:3 Topics: Angina Pectoris; Animals; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Risk Factors; Ventricular Dysfunction, Left	2011
[From results of BEAUTIFUL trial to results of SHIFT trial: BEAUTIFUL possibility to make a SHIFT in current guidelines]. Kardiologiia, 2011, Volume: 51, Issue:5 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Disease Progression; Evidence-Based Medicine; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Practice Guidelines as Topic; Randomized Controlled Trials as Topic	2011
[New agents for the therapy of angina pectoris]. Der Internist, 2011, Volume: 52, Issue:7 Topics: Acetanilides; Angina Pectoris; Benzazepines; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Drug Approval; Enzyme Inhibitors; Humans; Ivabradine; Nicorandil; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Vasodilator Agents	2011
Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina. The American journal of medicine, 2011, Volume: 124, Issue:8 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Ivabradine; Myocardial Revascularization; Nitrates; Piperazines; Ranolazine; Treatment Outcome	2011
The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine. Minerva medica, 2011, Volume: 102, Issue:5 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Cyclic Nucleotide-Gated Cation Channels; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Prognosis; Sinoatrial Node	2011
[Ivabradine (pure heart-rate-lowering agent)]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 9 Topics: Angina Pectoris; Animals; Benzazepines; Heart Failure; Heart Rate; Humans; Ivabradine; Mice	2011
Ivabradine for chronic heart failure? Drug and therapeutics bulletin, 2012, Volume: 50, Issue:10 Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Treatment Outcome	2012
Drug insight: If inhibitors as specific heart-rate-reducing agents. Nature clinical practice. Cardiovascular medicine, 2004, Volume: 1, Issue:2 Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Electric Conductivity; Heart; Heart Rate; Humans; Ion Channel Gating; Ion Channels; Ivabradine; Myocardial Contraction; Sinoatrial Node	2004
Evolving treatment strategies for chronic refractory angina. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:3 Topics: Acetanilides; Angina Pectoris; Arginine; Benzazepines; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Counterpulsation; Electric Stimulation Therapy; Humans; Ivabradine; Myocardial Revascularization; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Spinal Cord	2006
Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina. International journal of clinical practice, 2006, Volume: 60, Issue:2 Topics: Angina Pectoris; Animals; Anti-Arrhythmia Agents; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine; Maximum Tolerated Dose; Randomized Controlled Trials as Topic; Sinoatrial Node	2006
Therapeutic effects of I(f) blockade: evidence and perspective. Pharmacological research, 2006, Volume: 53, Issue:5 Topics: Angina Pectoris; Animals; Benzazepines; Heart Rate; Humans; Ion Channels; Ivabradine; Myocardial Ischemia; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left	2006
Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradine. Advances in cardiology, 2006, Volume: 43 Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Clinical Trials as Topic; Heart Conduction System; Heart Rate; Humans; Ion Channels; Ivabradine; Placebos	2006
Heart rate slowing versus other pharmacological antianginal strategies. Advances in cardiology, 2006, Volume: 43 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiotonic Agents; Clinical Trials as Topic; Heart Conduction System; Heart Rate; Humans; Ion Channels; Ivabradine; Nitrates; Placebos	2006
Novel If current inhibitor ivabradine: safety considerations. Advances in cardiology, 2006, Volume: 43 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Automobile Driving; Benzazepines; Bradycardia; Cardiotonic Agents; Cardiovascular Diseases; Clinical Trials as Topic; Eye; Heart Conduction System; Heart Rate; Humans; Ion Channels; Ivabradine; Sinoatrial Node	2006
[Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina]. Kardiologiia, 2006, Volume: 46, Issue:8 Topics: Angina Pectoris; Benzazepines; Heart Rate; Humans; Ivabradine; Sinoatrial Node; Stereoisomerism; Treatment Outcome	2006
Heart rate reduction via selective 'funny' channel blockers. Current opinion in pharmacology, 2007, Volume: 7, Issue:2 Topics: Angina Pectoris; Animals; Anti-Arrhythmia Agents; Benzazepines; Coronary Artery Disease; Drug Delivery Systems; Heart Rate; Humans; Ion Channel Gating; Ion Channels; Ivabradine; Sinoatrial Node	2007
I(f) current and heart rate control. Arquivos brasileiros de cardiologia, 2007, Volume: 88, Issue:4 Topics: Action Potentials; Angina Pectoris; Animals; Benzazepines; Calcium Channels; Cyclic Nucleotide-Gated Cation Channels; Electric Conductivity; Heart Rate; Humans; Ivabradine; Membrane Potentials; Rabbits; Sinoatrial Node; Sodium Channels	2007
Ivabradine: a new strategy for management of stable angina. British journal of hospital medicine (London, England : 2005), 2007, Volume: 68, Issue:6 Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Exercise Tolerance; Humans; Ivabradine; Treatment Outcome	2007
Clinical results of I(f) current inhibition by ivabradine. Drugs, 2007, Volume: 67 Suppl 2 Topics: Angina Pectoris; Benzazepines; Coronary Disease; Electrophysiology; Heart Failure; Heart Rate; Humans; Ion Channels; Ivabradine; Potassium; Sodium	2007
Ivabradine: a selective If current inhibitor in the treatment of stable angina. Recent patents on cardiovascular drug discovery, 2006, Volume: 1, Issue:3 Topics: Angina Pectoris; Animals; Benzazepines; Clinical Trials as Topic; Cyclic Nucleotide-Gated Cation Channels; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Muscle Proteins; Potassium Channels; Sinoatrial Node	2006
Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease. Clinical cardiology, 2007, Volume: 30, Issue:2 Suppl 1 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Chronic Disease; Enzyme Inhibitors; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Nitro Compounds; Piperazines; Ranolazine; rho-Associated Kinases; Sinoatrial Node; Trimetazidine; Vasodilator Agents	2007

Trials

19 trial(s) available for ivabradine and Angor Pectoris

Article	Year
Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. The American journal of cardiology, 2013, Jul-01, Volume: 112, Issue:1 Topics: Acetanilides; Analysis of Variance; Angina Pectoris; Benzazepines; Chi-Square Distribution; Coronary Angiography; Enzyme Inhibitors; Exercise Test; Female; Humans; Ivabradine; Male; Middle Aged; Piperazines; Placebos; Quality of Life; Ranolazine; Surveys and Questionnaires; Treatment Outcome	2013
[Relieve your patients of angina pectoris symptoms]. MMW Fortschritte der Medizin, 2015, Aug-20, Volume: 157, Issue:14 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine; Recurrence	2015
Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy. Circulation. Cardiovascular quality and outcomes, 2016, Volume: 9, Issue:1 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Female; Humans; Ivabradine; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Visual Analog Scale	2016
[Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease]. Zhonghua xin xue guan bing za zhi, 2016, Volume: 44, Issue:1 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Outpatients; Percutaneous Coronary Intervention; Prospective Studies; Registries; Risk Factors	2016
[Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina]. Kardiologiia, 2008, Volume: 48, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Benzazepines; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Ivabradine; Male; Stereoisomerism; Treatment Outcome	2008
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. European heart journal, 2009, Volume: 30, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Benzazepines; Blood Pressure; Cardiovascular Agents; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ion Channels; Ivabradine; Male; Middle Aged; Sinoatrial Node; Treatment Outcome; Young Adult	2009
[Antianginal effect of long-term use of ivabradine in patients with ischemic heart disease and diabetes in ambulatory conditions]. Kardiologiia, 2009, Volume: 49, Issue:3 Topics: Adrenergic Antagonists; Aged; Ambulatory Care; Angina Pectoris; Benzazepines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome	2009
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. European heart journal, 2009, Volume: 30, Issue:19 Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Coronary Artery Disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Hospitalization; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left; Young Adult	2009
Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study. American heart journal, 2009, Volume: 158, Issue:4 Topics: Aged; Angina Pectoris; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Germany; Heart Rate; Humans; Ivabradine; Male; Prospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome	2009
Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus. The American journal of cardiology, 2010, Jan-01, Volume: 105, Issue:1 Topics: Angina Pectoris; Benzazepines; Blood Glucose; Cyclic Nucleotide-Gated Cation Channels; Diabetes Mellitus; Double-Blind Method; Electrocardiography; Exercise Tolerance; Female; Follow-Up Studies; Humans; Ivabradine; Male; Middle Aged; Treatment Outcome	2010
Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice. Clinical research in cardiology : official journal of the German Cardiac Society, 2010, Volume: 99, Issue:10 Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzazepines; Drug Therapy, Combination; Female; Humans; Ivabradine; Male; Membrane Transport Modulators; Middle Aged; Treatment Outcome	2010
Ivabradine for the treatment of stable angina pectoris in octogenarians. Clinical research in cardiology : official journal of the German Cardiac Society, 2011, Volume: 100, Issue:2 Topics: Aged, 80 and over; Angina Pectoris; Benzazepines; Bradycardia; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Ivabradine; Male	2011
[Dynamics of structural functional parameters of cardiovascular system in patients with Stable Angina and Congestive Heart Failure treated with Ivabradine for six months]. Kardiologiia, 2010, Volume: 50, Issue:9 Topics: Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Endothelium; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Treatment Outcome; von Willebrand Factor	2010
[The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease]. Kardiologiia, 2010, Volume: 50, Issue:10 Topics: Administration, Inhalation; Adrenergic beta-1 Receptor Antagonists; Aged; Angina Pectoris; Benzazepines; Bisoprolol; Bronchodilator Agents; Cyclic Nucleotide-Gated Cation Channels; Drug Dosage Calculations; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Monitoring, Physiologic; Patient Readmission; Pulmonary Disease, Chronic Obstructive; Quality of Life; Treatment Outcome	2010
[Antianginal efficacy and tolerability of ivabradine in the therapy of patients with stable angina: results of the CONTROL study]. Kardiologiia, 2010, Volume: 50, Issue:11 Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Depression, Chemical; Drug Monitoring; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Prognosis; Severity of Illness Index; Treatment Outcome	2010
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation, 2003, Feb-18, Volume: 107, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzazepines; Depression, Chemical; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Sinoatrial Node; Treatment Outcome; Vision Disorders	2003
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. European heart journal, 2005, Volume: 26, Issue:23 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Exercise Tolerance; Female; Heart Conduction System; Humans; Ion Channels; Ivabradine; Male; Middle Aged	2005
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Drugs, 2007, Volume: 67, Issue:3 Topics: Aged; Amlodipine; Angina Pectoris; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Double-Blind Method; Electrocardiography; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Nitrates	2007
Long-term safety and efficacy of ivabradine in patients with chronic stable angina. Cardiology, 2007, Volume: 108, Issue:4 Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Female; Humans; Ivabradine; Male; Middle Aged; Treatment Outcome	2007

Other Studies

29 other study(ies) available for ivabradine and Angor Pectoris

Article	Year
Ivabradine and atrial fibrillation: what should we tell our patients? Heart (British Cardiac Society), 2014, Volume: 100, Issue:19 Topics: Angina Pectoris; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Medication Therapy Management; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment	2014
[Symptomatic coronary heart disease. Therapy with a beta blocker and ivabradine combination]. MMW Fortschritte der Medizin, 2014, Jun-12, Volume: 156, Issue:11 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Coronary Disease; Drug Therapy, Combination; Guideline Adherence; Heart Failure; Humans; Ivabradine; Survival Rate	2014
[Symptomatic coronary heart diseases. Combination therapy is successful in general practice]. MMW Fortschritte der Medizin, 2014, Nov-20, Volume: 156, Issue:20 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Clinical Trials as Topic; Coronary Disease; Drug Combinations; Heart Rate; Humans; Ivabradine	2014
Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy. The American journal of cardiology, 2016, 05-15, Volume: 117, Issue:10 Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Echocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Ivabradine; Male; Myocardial Ischemia; Ranolazine; Retrospective Studies; Sodium Channel Blockers; Stroke Volume; Systole; Time Factors; Tomography, Emission-Computed, Single-Photon; Trimetazidine; Vasodilator Agents; Ventricular Function, Left	2016
[First fixed combination becomes available]. MMW Fortschritte der Medizin, 2016, May-25, Volume: 158, Issue:10 Topics: Angina Pectoris; Benzazepines; Coronary Disease; Drug Combinations; Humans; Ivabradine; Metoprolol	2016
[Anti-angina fixed combination is available]. MMW Fortschritte der Medizin, 2016, Apr-28, Volume: 158, Issue:8 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Cardiovascular Agents; Combined Modality Therapy; Coronary Disease; Drug Combinations; Humans; Ivabradine; Metoprolol; Recurrence	2016
[Increased physical capacity]. MMW Fortschritte der Medizin, 2016, May-12, Volume: 158, Issue:9 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Combinations; Humans; Ivabradine; Metoprolol; Physical Fitness	2016
[Causes of Angina Pectoris in Survivors of Myocardial Infarction and the Role of Optimization of Antianginal Therapy. Data of the LINKOR Study E..] Kardiologiia, 2016, Volume: 56, Issue:11 Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Female; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Quality of Life; Risk Factors	2016
[The program ALTERNATIVA--investigation of antianginal efficacy and tolerability of coraxan (ivabradine) and assessment of quality of life of patients with stable angina: results of an epidemiological stage]. Kardiologiia, 2008, Volume: 48, Issue:5 Topics: Angina Pectoris; Benzazepines; Female; Follow-Up Studies; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Morbidity; Quality of Life; Retrospective Studies; Russia; Stereoisomerism; Treatment Outcome	2008
A new combination therapy in stable angina pectoris. European heart journal, 2009, Volume: 30, Issue:5 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Humans; Ivabradine; Treatment Outcome	2009
Angina: Ivabradine for treatment of stable angina pectoris. Nature reviews. Cardiology, 2009, Volume: 6, Issue:5 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Heart Rate; Humans; Ivabradine; Treatment Outcome	2009
Ivabradine versus bisoprolol. Minerva cardioangiologica, 2010, Volume: 58, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Bisoprolol; Heart Rate; Humans; Ivabradine; Male; Middle Aged	2010
[Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine]. MMW Fortschritte der Medizin, 2010, May-27, Volume: 152, Issue:21 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Drug Therapy, Combination; Humans; Ivabradine; Randomized Controlled Trials as Topic	2010
[Possibilities of if channels inhibitor ivabradine in complex treatment of survivors of myocardial infarction with stable angina]. Kardiologiia, 2010, Volume: 50, Issue:5 Topics: Aged; Angina Pectoris; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Echocardiography; Follow-Up Studies; Humans; Ivabradine; Middle Aged; Myocardial Infarction; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome	2010
Stable angina: role of ivabradine unchanged between 2006 and 2010. Prescrire international, 2010, Volume: 19, Issue:110 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine; Randomized Controlled Trials as Topic	2010
[Antianginal efficacy of ivabradine in a very old patient with aortic stenosis: effects on cardiac output and transvalvular aortic gradients]. Giornale italiano di cardiologia (2006), 2010, Volume: 11, Issue:9 Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Angina Pectoris; Aortic Valve Stenosis; Benzazepines; Cardiotonic Agents; Drug Therapy, Combination; Humans; Ivabradine; Male; Myocardial Infarction	2010
Ivabradine in combination with a beta-blocker. Stable angina: do not use instead, of or, with a beta-blocker. Prescrire international, 2010, Volume: 19, Issue:111 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine	2010
[Angina pectoris: improving symptoms and prognosis. With ivabradine less angina pectoris and reduced need for nitrates]. MMW Fortschritte der Medizin, 2011, Jun-16, Volume: 153, Issue:24-25 Topics: Angina Pectoris; Benzazepines; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans; Ivabradine; Nitric Oxide Donors; Prognosis; Randomized Controlled Trials as Topic; Vasodilator Agents	2011
[Reducing heart rate to treat angina pectoris]. Revue medicale suisse, 2011, Jun-08, Volume: 7, Issue:298 Topics: Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic	2011
[Update coronary artery disease: important progresses in acute and chronic therapy]. MMW Fortschritte der Medizin, 2012, Mar-22, Volume: 154, Issue:5 Topics: Acetanilides; Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Coronary Artery Disease; Early Medical Intervention; Humans; Ivabradine; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ranolazine; Survival Rate; Thrombolytic Therapy	2012
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectoris. Journal of pharmacokinetics and pharmacodynamics, 2002, Volume: 29, Issue:4 Topics: Angina Pectoris; Benzazepines; Chi-Square Distribution; Clinical Trials, Phase III as Topic; Double-Blind Method; Humans; Ivabradine; Models, Biological; Monte Carlo Method; Randomized Controlled Trials as Topic	2002
[Ivabradine -- a novel approach for heart rate lowering]. Deutsche medizinische Wochenschrift (1946), 2005, Jun-17, Volume: 130, Issue:24 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Contraindications; Electrocardiography; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Infarction; Randomized Controlled Trials as Topic; Sinoatrial Node; Treatment Outcome; Ventricular Function, Left	2005
If at first you don't succeed try ... a new target in the treatment of angina. European heart journal, 2005, Volume: 26, Issue:23 Topics: Angina Pectoris; Benzazepines; Chronic Disease; Humans; Ion Channels; Ivabradine	2005
Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:9 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Nitrates; Randomized Controlled Trials as Topic; Sinoatrial Node	2006
[Possibilities of reducing heart rate by I(f)-channel inhibitors]. Medizinische Klinik (Munich, Germany : 1983), 2006, Mar-22, Volume: 101 Suppl 1 Topics: Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Cause of Death; Cyclic Nucleotide-Gated Cation Channels; Electrocardiography; Exercise Test; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Muscle Proteins; Myocardial Infarction; Potassium Channels; Prognosis; Randomized Controlled Trials as Topic; Sinoatrial Node; Stereoisomerism; Tachycardia	2006
[A new medicine for treatment of stable angina pectoris]. Terapevticheskii arkhiv, 2006, Volume: 78, Issue:5 Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Heart Rate; Humans; Ivabradine	2006
[Heart rate reduction as a therapeutic strategy: novel options]. Der Internist, 2006, Volume: 47, Issue:12 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Coronary Disease; Electrocardiography; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Contraction; Survival Rate	2006
[Ivabradine--a medical alternative for patients with chronic stable angina pectoris]. Ugeskrift for laeger, 2006, Nov-13, Volume: 168, Issue:46 Topics: Angina Pectoris; Benzazepines; Chronic Disease; Humans; Ivabradine	2006
The role of heart rate reduction in angina management and beyond. British journal of hospital medicine (London, England : 2005), 2008, Volume: 69, Issue:4 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Heart Rate; Humans; Ivabradine; Risk Factors	2008